The Centers for Medicare and Medicaid Services (CMS) issued a final Medicare Advantage technical rule that removes regulations for the use of artificial intelligence but maintains a Biden-era provision that restricts plans from modifying approved hospital decisions, and raises MA funding by 5%.
The rule also removed proposals for...
The Hertel Report compiled the Medicare Advantage Prescription Drug Plans competing in Arizona during this year's open enrollment period beginning October 15, 2024. Get all the highlights here; CMS published star ratings on October 10, 2024.
...
Last week the federal government began its initial pitch during its month-long negotiations with Johnson & Johnson, Merck, Bristol Myers, Squibb, Pfizer and other drug makers regarding how much Medicare is willing to pay for 10 costly cancer, diabetes and heart disease drugs.
The U.S. government gained authority to negotiate the...
Medicare open enrollment begins this week with Medicare Advantage enrollment expected to climb as it has consistently in past years. As the Centers for Medicare and Medicaid Services announce new cost sharing information for Part D plans, and new brokers prepare to enter the market, here are some things to look out for this enrollment...
The Centers for Medicare and Medicaid Services has finalized a rule intended to make prices more transparent with Medicare Part D drug plans and allow plan sponsors to use cost-cutting tools such as step therapy under certain circumstances.
"CMS is delivering on price transparency, because patients have a right to know the cost of...
